156 related articles for article (PubMed ID: 25147908)
1. A comparison of assay performance between the calcium mobilization and the dynamic mass redistribution technologies for the human urotensin receptor.
Lee MY; Mun J; Lee JH; Lee S; Lee BH; Oh KS
Assay Drug Dev Technol; 2014 Aug; 12(6):361-8. PubMed ID: 25147908
[TBL] [Abstract][Full Text] [Related]
2. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
3. Development of Novel
Poret B; Desrues L; Bonin MA; Pédard M; Dubois M; Leduc R; Modzelewski R; Decazes P; Morin F; Vera P; Castel H; Bohn P; Gandolfo P
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32204509
[TBL] [Abstract][Full Text] [Related]
4. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
[TBL] [Abstract][Full Text] [Related]
5. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
[TBL] [Abstract][Full Text] [Related]
6. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.
Camarda V; Song W; Marzola E; Spagnol M; Guerrini R; Salvadori S; Regoli D; Thompson JP; Rowbotham DJ; Behm DJ; Douglas SA; Calo' G; Lambert DG
Eur J Pharmacol; 2004 Sep; 498(1-3):83-6. PubMed ID: 15363979
[TBL] [Abstract][Full Text] [Related]
7. The UII/UT system mediates upregulation of proinflammatory cytokines through p38 MAPK and NF-κB pathways in LPS-stimulated Kupffer cells.
Liu LM; Liang DY; Ye CG; Tu WJ; Zhu T
PLoS One; 2015; 10(3):e0121383. PubMed ID: 25803040
[TBL] [Abstract][Full Text] [Related]
8. [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes.
Diallo M; Jarry M; Desrues L; Castel H; Chatenet D; Leprince J; Vaudry H; Tonon MC; Gandolfo P
Peptides; 2008 May; 29(5):813-9. PubMed ID: 18082287
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of no-wash calcium assay kits: enabling tools for calcium mobilization.
Xin H; Wang Y; Todd MJ; Qi J; Minor LK
J Biomol Screen; 2007 Aug; 12(5):705-14. PubMed ID: 17537987
[TBL] [Abstract][Full Text] [Related]
10. GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo.
Behm DJ; Aiyar NV; Olzinski AR; McAtee JJ; Hilfiker MA; Dodson JW; Dowdell SE; Wang GZ; Goodman KB; Sehon CA; Harpel MR; Willette RN; Neeb MJ; Leach CA; Douglas SA
Br J Pharmacol; 2010 Sep; 161(1):207-28. PubMed ID: 20718751
[TBL] [Abstract][Full Text] [Related]
11. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
Kristof AS; You Z; Han YS; Giaid A
Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
[TBL] [Abstract][Full Text] [Related]
12. UII and UT in grouper: cloning and effects on the transcription of hormones related to growth control.
Sun C; Duan D; Li B; Qin C; Jia J; Wang B; Dong H; Li W
J Endocrinol; 2014 Jan; 220(1):35-48. PubMed ID: 24169050
[TBL] [Abstract][Full Text] [Related]
13. Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats.
Wang T; Xie YQ; Miao GX; Cui HP; Liu K; Li Y; Li Y; Zhao J
Life Sci; 2020 Apr; 247():117421. PubMed ID: 32061865
[TBL] [Abstract][Full Text] [Related]
14. In vitro siRNA-mediated knockdown of the UT receptor: implications of density on the efficacy of a range of UT ligands.
Hunt BD; Ng LL; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):651-6. PubMed ID: 22315015
[TBL] [Abstract][Full Text] [Related]
15. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function.
Vaudry H; Leprince J; Chatenet D; Fournier A; Lambert DG; Le Mével JC; Ohlstein EH; Schwertani A; Tostivint H; Vaudry D
Pharmacol Rev; 2015; 67(1):214-58. PubMed ID: 25535277
[TBL] [Abstract][Full Text] [Related]
16. Urotensin II evokes neurotransmitter release from rat cerebrocortical slices.
Ono T; Kawaguchi Y; Kudo M; Kushikata T; Hashiba E; Yoshida H; Kudo T; Furukawa K; Douglas SA; Guerrini R; Calo' G; Hirota K
Neurosci Lett; 2008 Aug; 440(3):275-9. PubMed ID: 18572318
[TBL] [Abstract][Full Text] [Related]
17. Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro.
Spinazzi R; Albertin G; Nico B; Guidolin D; Di Liddo R; Rossi GP; Ribatti D; Nussdorfer GG
Int J Mol Med; 2006 Dec; 18(6):1107-12. PubMed ID: 17089015
[TBL] [Abstract][Full Text] [Related]
18. Towards Targeting the Urotensinergic System: Overview and Challenges.
Nassour H; Iddir M; Chatenet D
Trends Pharmacol Sci; 2019 Oct; 40(10):725-734. PubMed ID: 31500846
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity.
Desrues L; Lefebvre T; Lecointre C; Schouft MT; Leprince J; Compère V; Morin F; Proust F; Gandolfo P; Tonon MC; Castel H
PLoS One; 2012; 7(5):e36319. PubMed ID: 22563490
[TBL] [Abstract][Full Text] [Related]
20. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation.
Billard E; Létourneau M; Hébert TE; Chatenet D
Biochem Pharmacol; 2017 Nov; 144():100-107. PubMed ID: 28784291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
